Skip to main content
SpringerLink
Log in

Treatment of Lymphocytic Myocarditis

  • Chapter
Myocarditis

  • 198 Accesses

Abstract

How to treat lymphocytic myocarditis has changed in the last 50 years from a simple, unanswered clinical question to a highly complex, but still unanswered, clinical and basic research inquiry. The early literature, which preceded the now huge basic science exploration of myocarditis, speculated on its immunologic causes and the potential utility of steroid therapy.1,2 Clinical recognition of the many causes of myocarditis and fundamental basic research observations on disease mechanisms have led to a long list of potential therapies. Although only a few of them have been tested satisfactorily in clinical trials, therapies being considered are remarkably innovative and promising.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Garrison RF, Swisher RC. Myocarditis of unknown etiology (Fiedler’s ?) treated with ACTH: report of a case in a 7-year-old boy with improvement. J Pediatr 1953;42:591–599.

    Article  PubMed  CAS  Google Scholar 

  2. Ainger LE. Acute aseptic myocarditis: corticosteroid therapy. J Pediatr 1964;64:716–723.

    Article  PubMed  CAS  Google Scholar 

  3. Orinius E. The late cardiac prognosis after Coxsackie-B infection. Acta Med Scand 1968;183:235–237.

    Article  PubMed  CAS  Google Scholar 

  4. Bowles NE, Richardson PJ, Olsen EG, Archard LC. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;1:1120–1123.

    Article  PubMed  CAS  Google Scholar 

  5. Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, Camerini F. Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1033–1040.

    Article  PubMed  CAS  Google Scholar 

  6. Weiss LM, Movahed LA, Billingham ME, Cleary ML. Detection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am J Pathol 1991;138:497–503.

    PubMed  CAS  Google Scholar 

  7. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252–257.

    Article  PubMed  CAS  Google Scholar 

  8. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, Murali S, Feldman AM. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997;95:2476–2478.

    Article  PubMed  CAS  Google Scholar 

  9. Liu PP, Opavsky MA. Viral myocarditis: receptors that bridge the cardiovascular with the immune system? Circ Res 2000;86:253–254.

    Article  PubMed  CAS  Google Scholar 

  10. Anderson DW, Virmani R, Reilly JM, O’Leary T, Cunnion RE, Robinowitz M, Macher AM, Punja t, Villaflor ST, Parrillo JE, Roberts WC. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 1988;11:792–799.

    Article  PubMed  CAS  Google Scholar 

  11. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998;339:1093–1099.

    Article  PubMed  CAS  Google Scholar 

  12. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS Investigators. AIDS Res Hum Retroviruses 1998;14:1071–1077.

    Article  PubMed  CAS  Google Scholar 

  13. Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome: a 1991 update. Am Heart J 1991;122:535–544.

    Article  PubMed  CAS  Google Scholar 

  14. De Castro S, d’Amati G, Gallo P, Cartoni D, Santopadre P, Vullo V, Cirelli A, Migliau G. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol 1994;24:1018–1024.

    Article  PubMed  Google Scholar 

  15. Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis 2000;181 Suppl 1:S110–S115.

    Google Scholar 

  16. Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269–275.

    Article  PubMed  CAS  Google Scholar 

  17. Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980;101:425–484.

    PubMed  CAS  Google Scholar 

  18. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998;129:317–322.

    Article  PubMed  CAS  Google Scholar 

  19. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3–14.

    PubMed  CAS  Google Scholar 

  20. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690–695.

    Article  PubMed  Google Scholar 

  21. Kato S, Morimoto S, Hiramitsu S, Nomura M, Ito T, Hishida H. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol 1999;83:623–625, A10.

    Article  PubMed  CAS  Google Scholar 

  22. Kawahito K, Murata S, Yasu T, Adachi H, Ino T, Saito M, Misawa Y, Fuse K, Shimada K. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol 1998;82:910–911.

    Article  PubMed  CAS  Google Scholar 

  23. Starling RC, Galbraith TA, Baker PB, Howanitz EP, Murray KD, Binkley PF, Watson KM, Unverferth DV, Myerowitz PD. Successful management of acute myocarditis with biventricular assist devices and cardiac transplantation. Am J Cardiol 1988;62:341–343.

    Article  PubMed  CAS  Google Scholar 

  24. Reiss N, el-Banayosy A, Posival H, Morshuis M, Minami K, Korfer R. Management of acute fulminant myocarditis using circulatory support systems. Artif Organs 1996;20:964–970.

    Article  PubMed  CAS  Google Scholar 

  25. Brilakis ES, Olson LJ, Berry GJ, Daly RC, Loisance D, Zucker M, Cooper LT Jr. Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices. Asaio J 2000;46:569–572.

    Article  PubMed  CAS  Google Scholar 

  26. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000;101:385–391.

    Article  PubMed  CAS  Google Scholar 

  27. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994;89:846–851.

    Article  PubMed  CAS  Google Scholar 

  28. Iwasaki A, Matsumori A, Yamada T, Shioi T, Wang W, Ono K, Nishio R, Okada M, Sasayama S. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. J Am Coll Cardiol 1999;33:1400–1407.

    Article  PubMed  CAS  Google Scholar 

  29. Matsumoto Y, Jee Y, Sugisaki M. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 2000;164:2248–2254.

    PubMed  CAS  Google Scholar 

  30. Kanda T, Nagaoka H, Kaneko K, Wilson JE, McManus BM, Imai S, Suzuki T, Murata K, Kobayashi I. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis. J Pharmacol Exp Ther 1995;274:487–493.

    PubMed  CAS  Google Scholar 

  31. Hanawa H, Kodama M, Zhang S, Izumi T, Shibata A. An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats. Clin Immunol Immunopathol 1992;62:321–326.

    Article  PubMed  CAS  Google Scholar 

  32. McManus BM, Han L, Caruso R, Stratta RJ, Wilson JE. Impact of FK 506 on myocarditis in the enteroviral murine model. Transplant Proc 1991;23:3365–3367.

    PubMed  CAS  Google Scholar 

  33. Kitabayashi H, Isobe M, Watanabe N, Suzuki J, Yazaki Y, Sekiguchi M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardiovasc Pharmacol 2000;35:410–416.

    Article  PubMed  CAS  Google Scholar 

  34. Matsui S, Matsumori A, Matoba Y, Uchida A, Sasayama S. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest 1994;94:1212–1217.

    Article  PubMed  CAS  Google Scholar 

  35. Rezkalla S, Kloner RA, Khatib G, Smith FE, Khatib R. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis. J Am Coll Cardiol 1988;12:412–414.

    Article  PubMed  CAS  Google Scholar 

  36. Nishio R, Matsumori A, Shioi T, Wang W, Yamada T, Ono K, Sasayama S. Denopamine, a betaiadrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. J Am Coll Cardiol 1998;32:808–815.

    Article  PubMed  CAS  Google Scholar 

  37. Tominaga M, Matsumori A, Okada I, Yamada T, Kawai C. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. Circulation 1991;83:2021–2028.

    Article  PubMed  CAS  Google Scholar 

  38. Wang WZ, Matsumori A, Yamada T, Shioi T, Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 1997;95:245–251.

    Article  PubMed  Google Scholar 

  39. Yamada T, Matsumori A, Okada I, Tominaga M, Kawai C. The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. Jpn Circ J 1992;56:1138–1145.

    Article  PubMed  CAS  Google Scholar 

  40. Rezkalla S, Kloner RA, Khatib G, Khatib R. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation 1990 81:1039–1046.

    Article  PubMed  CAS  Google Scholar 

  41. Wang WZ, Matsumori A, Matoba Y, Matsui S, Sato Y, Hirozane T, Shioi T, Sasayama S. Protective effects of Mu-Fang-Ji-Tang against myocardial injury in a murine model of congestive heart failure induced by viral myocarditis. Life Sci 1998;62:1139–1146.

    Article  PubMed  CAS  Google Scholar 

  42. Ferrans VJ, Rodriguez ER. Cardiovascular lesions in collagen-vascular diseases. Heart Vessels Suppl 1985;1:256–261.

    Article  PubMed  CAS  Google Scholar 

  43. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630–3636.

    PubMed  CAS  Google Scholar 

  44. Rose NR. Viral damage or ‘molecular mimicry’—placing the blame in myocarditis. Nat Med 2000;6:631–632.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jay W. Mason M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

    Leslie T. Cooper Jr. MD (Consultant, Assistant Professor of Medicine) (Consultant, Assistant Professor of Medicine)

  2. Mayo Medical School, Rochester, Minnesota, USA

    Leslie T. Cooper Jr. MD (Consultant, Assistant Professor of Medicine) (Consultant, Assistant Professor of Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mason, J.W. (2003). Treatment of Lymphocytic Myocarditis. In: Cooper, L.T. (eds) Myocarditis. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-319-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-319-4_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-366-4

  • Online ISBN: 978-1-59259-319-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation